JPRO
  • Home
    • English Top
    • 日本語トップ
  • Table of Contents (English)
    • Business Setup & Operations >
      • Startup Visa
      • Setting up a Business in Japan
      • ​How Foreign Startups Can Raise Funds in Japan
      • Company establishment
      • Life Science Hub, Startup Hub
    • Public Support >
      • Home-Country Public Support for Entering the Japanese Market
      • Using JETRO for Japan Market Entry|JPRO
      • Public Support in Yokohama city
    • Regulatory & Compliance >
      • PMDA Consultation Guide for Foreign Companies | RS Consultation | JPRO
      • Guide to Selecting Regulatory Affairs Staff and Consultants
      • Expedited Review Systems for Pharmaceuticals
      • Guidelines for Establishing Generic Drug Names
      • Combination Products, Combination Medical Devices, Kit Products, Combination Drugs
    • Medical Device, IVD >
      • IVD, LDT, RUO
      • DMAH: Designated Marketing Authorization Holder-Summary Ver.
      • Combination Products, Combination Medical Devices, Kit Products, Kit Components, Assortment Products
      • How to determine if a product is a medical device
      • Japan Medical Device Class I–IV|JPRO
      • Classification of Medical Devices
      • how to confirm JMDN of medical device
      • medical device & IVD reimbursement-Summary Ver.
      • medical device & IVD reimbursemenet
      • Comparison of Medical Device Definitions: Japan, US, & EU
      • Companion Diagnostics and Gene Panel Testing
    • Pharmaceutical, regenerative medicine >
      • How to determine if a product is a Pharmaceutical Drug
      • Advanced Medical Care System
      • Over-The-Counter (OTC) Drug
      • References on Reimbursement (Cost Calculation) for Regenerative Medical Products
    • Healthcare & Caretech Products >
      • guidance for non medical services
      • Therapeutic Orthoses and Assistive Devices
      • Cosmetics and Quasi-Drugs
      • Overseas Expansion of Non-Medical Device Products as Medical Devices: Learning from the Case of PARO
      • Medical Device vs Non-Medical Device
    • Funding, Partnering & Networking >
      • Utilization of Public Grants and Subsidies
      • J-Ships
    • Intellectual Property >
      • patent or trade secret?
      • employee invention
      • Matching of Patents Held by Startups and Individuals
    • Legal & Contracts >
      • References for Contracts
      • Guide to Industry-Academia Collaboration Agreements for Academic Researchers
    • Licensing, partnering >
      • Networking & Partnering in Japan for Life Science | JPRO
      • Introducing Seeds to Pharmaceutical Companies
      • Incentives (Returns) to Licensor Universities
    • References in English
  • コンテンツ一覧
    • 起業、法人設立・運営 >
      • 事業計画の策定
      • 法人設立
      • ライフサイエンスハブ、スタートアップハブ
    • 公的支援 >
      • 公的支援機関リスト|目的別で探す|JPRO
      • AMED 支援リスト
      • NEDOスタートアップ支援リスト
      • 実証実験支援プログラム一覧
      • 橋渡し研究・公的アクセラレーション・伴走支援一覧|JPRO
      • アカデミア発スタートアップ支援機関・プログラムガイド
    • 薬事・規制関連 >
      • PMDA RS相談活用のススメ
      • 薬事スタッフ・コンサル選定ガイド
      • 都道府県薬務課一覧
      • コンビネーション製品、組合せ医療機器、キット製品、組合せ医薬品
      • グレーゾーン解消制度、新事業特例制度、規制のサンドボックス
    • 医薬品、再生医療等製品 >
      • 医薬品の該当性確認方法
      • 医薬品一般的名称設定のガイドライン
      • 医薬品、医療機器等の開発に当たって参照したい資料
      • 先進医療制度
      • 一般用医薬品(OTC)
      • コンパニオン診断薬と遺伝子パネル検査
      • 再生医療等製品の保険償還(原価計算)に関する参考情報
    • 医療機器、体外診断用医薬品 >
      • 体外診、ラボ開発検査、研究用試薬
      • 医療機器該当性確認ガイド
      • 医療機器と非医療機器の機能が複合した製品は?
      • 医療機器の一般的名称と確認方法
      • 医療機器クラス分類(I〜IV)一覧と調べ方|JPRO
      • 医療機器・体外診の保険収載概要
      • 医療機器・体外診の保険収載実務
      • SaMDの保険収載
      • 医療機器・体外診の保険収載ガイド
    • ヘルスケア・ケアテック >
      • 非医療分野の検査サービスを展開する際に注意すべきポイント
      • 治療用装具と補装具
      • 化粧品及び医薬部外品
      • 医療機器 vs 非医療機器|ポジショニング戦略の検討ポイント|JPRO
    • 資金調達 >
      • 資金調達方法を知る
      • 公的な助成金、補助金の活用
      • 特定投資家向け銘柄制度(J-Ships)
      • アカデミア研究者がPIとして応募可能なグラントリスト
      • 海外在住の日本人研究者が日本の助成金を獲得する方法
      • 日本企業が現地法人設立せずに応募可能な助成金等リスト
    • 知的財産 >
      • アカデミア研究者・産学連携部門のための 知財に関する公的支援プロӞ
      • 特許か?営業秘密か?
      • 職務発明:アカデミア・公的研究機関に所属する研究者が注意すべきポ
      • スタートアップや個人が保有する特許のマッチング
      • ライセンスを受けた大学へのインセンティブ(還元)について
    • 法務・契約 >
      • 契約関連で参考になる公的機関の資料
      • 個人情報を利用する製品開発時に留意すべき法規制
    • アカデミア、技術移転 >
      • アカデミア研究者のための産学連携契約ガイド
    • ライセンシング、パートナリング >
      • 製薬企業等へのシーズ紹介
      • ネットワーキング、パートナリング
    • 海外展開 >
      • 米国展開(主に医療機器)に、読むと役立つ情報リスト
      • 米国FDAにおける、医療機器該当性の確認ステップ
      • 米国における、医療機器の申請データ・試験計画の相談方法((Pre-Submission/Q-Submission
      • 公的機関の海外展開支援
      • 横浜市の公的支援サービス
      • JETROを徹底活用しよう
      • 日米欧での医療機器定義の比較
      • 簡略審査(審査の迅速化)
      • 海外規制等の情報収集
      • 非医療機器製品の海外での医療機器展開
      • 欧州医療機器規則MDRに関する資料
      • 欧州MDRにおける、医療機器該当性の確認方法
    • オーストラリア >
      • オーストラリア研究開発優遇税制の概要
      • オーストラリア研究開発優遇税制の適用を受けるには
      • オーストラリアでの主要イベント
      • R&D関連の公的機関
      • オーストラリア助成金情報

How to Determine if Your Product Is a Medical Device in Japan

A practical guide for English speakers on how to judge whether a product qualifies as a “medical device” under Japan’s PMD Act. It covers the legal definition, how the purpose of use and degree of risk drive the decision, how to check the JMDN and device class, special rules for software (SaMD), worked examples (CYBERDYNE HAL and Apple Watch), what to do when a product is not a medical device, and how to consult the authorities. It also notes points relevant to entering Japan from overseas.

⚠️ Before you start

① English materials are scarce. Most official Japanese-government materials (PMDA, MHLW, etc.) are Japanese-only or machine-translated; the Japanese original prevails. References here are tagged (Japanese) / (English) / (Japanese / English).

② Authorities and public support are largely Japan-focused and in Japanese. Official communication is mostly in Japanese, and many public-sector programs target Japanese companies, so some resources cited here may not apply to overseas companies. Check with each organization in advance whether they can support you in English and/or accept overseas companies.

③ So secure a Japan-based partner in advance — for example, a local Japanese speaker or an agent such as a DMAH (Designated Marketing Authorization Holder) — before entering the Japanese market.

Contents

  1. Definition of Medical Devices
  2. Key Points for Determination
  3. How to Make an Assessment (JMDN and Device Class)
  4. Special Rules for Software (SaMD)
  5. Worked Examples (HAL and Apple Watch)
  6. If Your Product Is a Medical Device: Who Acts in Japan?
  7. If Your Product Is NOT a Medical Device
  8. Consulting with the Authorities
  9. How to Prepare for a Consultation
  10. Reference materials in English
  11. Reference materials in Japanese
  12. Related JPRO Pages

1. Definition of Medical Devices

Put simply, whether a product is a medical device comes down to whether it falls within the legal definition. In recent years the authorities have compiled guidelines, notices, and case studies, so you can now make a reasonable preliminary judgment yourself by referring to them.

Definition of Medical Device (PMD Act, Article 2, Paragraph 4): A “medical device” means an instrument or apparatus, etc. (excluding regenerative medicine products) that is intended for the diagnosis, treatment, or prevention of diseases in humans or animals, or that is intended to affect the structure or functions of the body of humans or animals, and which is specified by a Cabinet Order.

This definition can be broken down as follows:

  • Purpose of use: intended to be used for the “diagnosis, treatment, or prevention of diseases” in humans or animals, or to “affect the structure or functions of the body.”
  • Form: instruments and apparatus, dental materials, medical supplies, sanitary articles, and programs (software) and their recording media.
  • Designation by Cabinet Order: even if the above requirements are met, the product must be specifically designated by a Cabinet Order.

References:

  • Act on Securing Quality, Efficacy and Safety of Products Including Pharmaceuticals and Medical Devices (医薬品、医療機器等の品質、有効性及び安全性の確保等に関する法律 / 昭和35年8月10日法律第145号), e-Gov, laws.e-gov.go.jp (Japanese)
  • Regarding the Applicability of Programs as Medical Devices — Basic Concepts (プログラムの医療機器該当性について(基本的な考え方)), MHLW, 000273985.pdf (Japanese)
  • English translation of the Act (provisional; only the Japanese text has legal effect — Act No. 50 of 2015 version, later amendments not reflected): PMD Act, Japanese Law Translation Database, japaneselawtranslation.go.jp (English)

2. Key Points for Determination

For both physical devices and software (SaMD), the approach is the same: a comprehensive judgment is made based on the purpose of use and the degree of risk.

“Whether a specific program falls under the category of a medical device under the Act is determined based on whether the program’s purpose of use and degree of risk fall under the definition of a medical device, based on the product’s labeling, explanatory materials, advertisements, etc., provided by the manufacturer or distributor.”

Purpose of use

The most important criterion is the purpose for which the manufacturer or distributor places the product on the market. Regulatory authorities determine the “purpose of use” based on the claims (indications/effects) made on the product’s label, instruction manual, advertisements, website, etc.

  • Example: even for the same EMS device, if the purpose is “to train muscles,” it is a general good (zakka); if it claims a medical effect such as “improvement of muscle atrophy,” it becomes a medical device.

Risk to the human body

Devices are classified into classes according to their degree of risk (see Section 3).

References:

  • Guidelines on the Applicability of Programs as Medical Devices (プログラムの医療機器該当性に関するガイドライン), MHLW, 000240233.pdf (Japanese)
  • Regarding the Applicability of Programs as Medical Devices — Basic Concepts (プログラムの医療機器該当性について(基本的な考え方)), MHLW, 000273985.pdf (Japanese)

3. How to Make an Assessment (JMDN and Device Class)

A practical sequence:

  • Check whether the product seems to qualify as a medical device based on its definition, purpose of use, etc.
  • If there are similar products, check whether they are classified as medical devices (look at their websites and package inserts).
  • For SaMD, check the flowcharts and case studies in the “Guidelines on the Applicability of Programs as Medical Devices” (プログラムの医療機器該当性に関するガイドライン) (000240233.pdf (Japanese)).
  • If time permits, also check the JMDN (Japan Medical Device Nomenclature):
    • Check whether there is an applicable name in the JMDN list.
    • Check the websites or package inserts of similar products to find their JMDN.
    • If the product fits the definition of that JMDN, it is highly likely to be a medical device.

What is a “JMDN”?

A JMDN is a kind of “classification name” for grouping medical devices according to their characteristics and uses. Knowing the JMDN helps you understand the device’s class and the rules that must be followed. For details, see how to confirm the JMDN of a medical device.

  • JMDN Search (一般的名称検索 / PMDA), std.pmda.go.jp (Japanese); English version: Standards for Medical Devices in Japan, std.pmda.go.jp/…/index_en.html (English)
  • Q&A on Determining the Applicability to JMDN of Medical Devices (医療機器の一般的名称への該当性判断に関する質疑応答集(Q&A)について), H290929_0000000_01.pdf (Japanese)

Device class (Class I–IV)

Once a product is a medical device, it is assigned to one of four risk-based classes, and the regulatory route differs by class:

  • Class I (general medical devices): lowest risk — self-notification (todokede).
  • Class II (controlled medical devices): low risk — third-party certification (for devices with a certification standard) or approval (shonin).
  • Class III / IV (specially-controlled medical devices): medium to high risk — approval (shonin) by the Minister (PMDA review).
  • Some devices are additionally designated as “specially-controlled maintenance medical devices” (tokutei hoshu kanri iryokiki).

For details and concrete examples, see Classification of Medical Devices. For products that combine medical-device and non-medical-device functions, see medical device classification for combined products and Combination Products, Combination Medical Devices, Kit Products, Kit Components, Assortment Products.

4. Special Rules for Software (SaMD)

For software/programs, the same purpose-of-use + risk logic applies, but two rules often surprise newcomers:

There is no “Class I” SaMD

A program that — even if it malfunctions — poses almost no risk to human life or health (i.e., a program equivalent to a Class I general medical device) is excluded from the scope of medical devices under the law. In other words, the lowest-risk software does not become a “Class I medical device”; it simply falls outside the definition.

  • Reference: Guidelines on the Applicability of Programs as Medical Devices — “Basic concept of applicability” (プログラムの医療機器該当性に関するガイドライン(令和5年3月31日改正)「該当性の基本的考え方」), revised March 31, 2023, MHLW, mhlw.go.jp (Japanese)

Programs distributed integrally with a physical product

“A program that is distributed integrally with a tangible product is judged for medical-device applicability as a single product, including the tangible part.” In other words, when software is bundled with hardware as one product, the whole product is assessed together.

  • References: Regarding the Applicability of Programs as Medical Devices — Basic Concepts (プログラムの医療機器該当性について(基本的な考え方)), MHLW, 000273985.pdf (Japanese); Partial amendment to the Guidelines (プログラムの医療機器該当性に関するガイドラインの一部改正について), 000252002.pdf (see p.5) (Japanese)

5. Worked Examples (HAL and Apple Watch)

Example 1 — Physical product: CYBERDYNE HAL® (Hybrid Assistive Limb®)

A good example of an almost identical device that is intentionally split into a non-medical and a medical version depending on the purpose of use and claims. HAL is a wearable device that reads bioelectric signals on the skin surface and assists the wearer’s intended movement.

  • HAL® Lumbar Type for Care Support / Pro (HAL自立支援用下肢タイプ Pro) – CYBERDYNE — non-medical device. It does not aim to treat disease; its purpose is “to assist weakened muscle movement to make sitting, standing, and walking easier.” This does not fall under the PMD Act definition of “medical device.” (Japanese)
  • HAL Medical Lower Limb Type (JP model) (HAL医療用下肢タイプ JPモデル) – CYBERDYNE — medical device. It targets patients with specific diseases (slowly progressive neuromuscular diseases with reduced walking function) and aims to improve walking function. The medical version was approved as a medical device after clinical trials demonstrated improvement in walking function. (Japanese)
    • Package insert: HT010910A-U01_R3.pdf (Japanese)
    • Review report (PMDA): PMDA review report (Japanese)

The websites and product wording also differ between the two versions — a useful model when designing your own positioning.

Example 2 — Software: Apple Watch

On a single device, “medical-device programs” and “non-medical programs” coexist. Comparing them makes SaMD applicability easier to understand.

Functions that ARE medical devices

  • ① ECG app — Class II controlled medical device. Approval No. 30200BZI00020000 (home-use electrocardiograph program). The user wears the watch at rest and touches the Digital Crown for ~30 seconds to obtain a single-channel ECG resembling Lead I; the app classifies it as sinus rhythm or possible atrial fibrillation and notifies the user. Why it qualifies: it performs medical inference and clearly aims to contribute to early detection of disease.
  • ② Irregular rhythm notification — Class II controlled medical device. Approval No. 30200BZI00021000 (home-use heart-rate monitor program). It periodically samples pulse data in the background and, after repeated detections suggestive of atrial fibrillation, notifies the user. Why it qualifies: it autonomously acquires, analyzes, classifies, and conditionally notifies, aiming to detect signs of a specific arrhythmia and prompt the user to seek care.
  • ③ Sleep apnea notification — Class II controlled medical device (approved September 2024). Approval No. 30600BZI00017000; JMDN name “home-use body-motion information analysis program” (JMDN code 71132002). Using accelerometer-derived body-motion data, it estimates breathing disturbances during sleep and, over a 30-day window, notifies the user of possible moderate-to-severe sleep apnea. Why it qualifies: multi-stage medical inference aimed at screening for moderate-to-severe sleep apnea.

Functions that are NOT medical devices

  • ④ Heart-rate display — measures and displays/graphs pulse (bpm). Not applicable: it only records/displays/graphs values without judging the presence of disease or prompting a medical visit. (Distinct from ②, a separate program aimed at detecting disease signs.)
  • ⑤ Blood Oxygen (SpO2) “wellness” — Apple explicitly limits this to general fitness/wellness, not a medical purpose. Not applicable. Note: if redesigned to judge disease risk and recommend a medical visit, it would likely become a medical-device program.
  • ⑥ Sleep tracking — estimates sleep stages and visualizes sleep quantity/quality. Not applicable: it does not diagnose/detect a specific disease. (Distinct from ③.)
  • ⑦ Steps / calories / activity — fitness/wellness “exercise management.” Not applicable.
  • ⑧ Wrist skin temperature — displays temperature trends only; Apple states it is not intended for medical diagnosis. Not applicable.
  • ⑨ High/low heart-rate alerts — notifies when a user-set threshold is crossed. Not applicable, because the threshold is chosen by the user and the program does not run its own medical algorithm to judge a specific disease. Gray zone: if changed to judge a specific disease via a medical algorithm and recommend a visit, it could approach the medical-device-program boundary.

These cases illustrate the core principle: within one device, classification turns on the purpose of use, the claims made, and whether the function detects disease signs / prompts a medical visit. For positioning strategy, see Medical Device vs Non-Medical Device.

6. If Your Product Is a Medical Device: Who Acts in Japan?

(This page is about applicability, so the following is only a brief pointer — not a full procedural guide.)

This is the same legal framework for Japanese and foreign companies — except that a company without a base in Japan cannot itself hold the marketing authorization or perform the domestic procedures. If your product is a medical device, you will need a domestic actor (a Marketing Authorization Holder) and, typically, a DMAH (Designated Marketing Authorization Holder); manufacturing sites overseas also need to be registered (Foreign Manufacturer registration), and Class II-and-above products require conformity with the QMS Ordinance. These are procedural matters beyond the scope of this applicability page. For details, see DMAH: Designated Marketing Authorization Holder – Summary Ver.

7. If Your Product Is NOT a Medical Device

“Not a medical device” does not mean “unregulated.” Depending on its claims and form, a product may instead fall under quasi-drugs, cosmetics, general goods (zakka), or health foods, each with very different rules. Designing your claims to stay outside the medical-device definition (or to fit a different category) is a legitimate strategy, but you must then comply with that category’s rules.

  • Cosmetics and Quasi-Drugs
  • Medical Device vs Non-Medical Device (positioning)
  • Guidance for non-medical services
  • Therapeutic Orthoses and Assistive Devices
  • Case study — taking a non-medical-device product to market as a medical device overseas: Learning from the Case of PARO

8. Consulting with the Authorities

Ultimately, confirm with the regulatory authorities. The contact point differs depending on whether the product is a (physical) medical device or software as a medical device.

  • List of consultation counters for medical-device applicability (医療機器の該当性に関する相談窓口一覧 / PMDA): 000225620.pdf (Japanese)
  • Medical devices → Prefectural Pharmaceutical Affairs Divisions (都道府県薬務主管部局相談窓口一覧). List (JFMDA): prefectural counter list (PDF) (Japanese)
  • Software as a Medical Device (SaMD) → Centralized Consultation Service for SaMD — Comprehensive Consultation for Medical Device Programs (SaMD一元的相談窓口(医療機器プログラム総合相談)), PMDA: pmda.go.jp (Japanese)

Note: PMDA does not itself decide whether an individual product is a medical device; for a formal determination, the route is in practice via a Japan-resident MAH (J-MAH). For how to make the most of consultations, see PMDA consultation and the free MEDISO free consultation service.

9. How to Prepare for a Consultation

When consulting the authorities, prepare the following in advance (as materials in Japanese) to get an accurate answer. Meetings are mostly conducted in Japanese, so bring a Japanese speaker — ideally someone with Japanese regulatory knowledge.

  • Product name and overview: what the product is and what it does.
  • Purpose of use and target users: who uses it, in what situations, and for what purpose.
  • Operating principle / algorithm: a technical explanation of how it works.
  • Input/output information: what is input and what is output.
  • Investigation of similar medical devices: existence and classification of similar products already approved in Japan and overseas.
  • Drafts of advertisements / promotional materials: website mockups, brochure drafts, etc., showing the intended claims and advertising.

Reference URLs:

  • Regarding Consultation on the Applicability of Medical Devices (医療機器の該当性に関する相談に当たって / PMDA), 000225620.pdf (Japanese)
  • PMDA Centralized Consultation Service for SaMD — application method/forms (SaMD一元的相談窓口(申込方法・様式)), pmda.go.jp (Japanese)

10. Reference materials in English

For readers who want sources they can read directly in English (note: each English page is a machine-assisted translation, attachments are often untranslated, and the Japanese original prevails):

  • PMD Act — English translation (provisional; Act No. 50 of 2015 version, later amendments not reflected), Japanese Law Translation Database, japaneselawtranslation.go.jp (English)
  • Regulations and Approval/Certification of Medical Devices, PMDA, pmda.go.jp/english (English)
  • Software as a Medical Device (SaMD), PMDA, pmda.go.jp/english (English)
  • Revision of Japanese Medical Device QMS Requirements (incl. English translation of the QMS Ordinance), PMDA, pmda.go.jp/english (English)
  • Frequently Asked Questions (FAQ; incl. “who determines device applicability”), PMDA, pmda.go.jp/english (English)
  • Invest Japan / Life Science sector, JETRO, jetro.go.jp (English)

11. Reference materials in Japanese

The following are useful primary sources and case studies available in Japanese. Many are referenced inline above; they are gathered here for convenience. (For documents that also have an English version, see Section 10.)

  • What kinds of medical devices are there? (医療機器にはどんなものがあります。/ PMDA), pmda.go.jp (Japanese)
  • Regarding the Applicability of Programs as Medical Devices — Basic Concepts (プログラムの医療機器該当性について(基本的な考え方)), MHLW, 000273985.pdf (Japanese)
  • Guidelines on the Applicability of Programs as Medical Devices (プログラムの医療機器該当性に関するガイドライン), MHLW, 000240233.pdf (Japanese)
  • Partial amendment to the Guidelines on the Applicability of Programs as Medical Devices (プログラムの医療機器該当性に関するガイドラインの一部改正について), 000252002.pdf (Japanese)
  • Case Studies on Determining the Applicability of Programs as Medical Devices (プログラムの医療機器該当性判断事例について / PMDA), 000251980.pdf (Japanese)
  • Case Studies on Determining the Applicability of Programs as Medical Devices (プログラムの医療機器該当性判断事例について / MHLW), mhlw.go.jp (Japanese)
  • Q&A on Determining the Applicability to JMDN of Medical Devices (医療機器の一般的名称への該当性判断に関する質疑応答集(Q&A)について), H290929_0000000_01.pdf (Japanese)
  • JMDN Search (一般的名称検索 / PMDA), std.pmda.go.jp (Japanese)
  • Let’s investigate the applicability to medical devices (医療機器への該当性を調べよう / JAAME), jaame.or.jp (Japanese)
  • Explanatory handbook on the Guidelines for the Applicability of Programs as Medical Devices, v1.0 (プログラムの医療機器該当性ガイドラインに関する解説書(医機連編)第1.0版), JFMDA, handbook (PDF) (Japanese)
  • Act on Securing Quality, Efficacy and Safety of Products Including Pharmaceuticals and Medical Devices (医薬品、医療機器等の品質、有効性及び安全性の確保等に関する法律 / 昭和35年8月10日法律第145号), e-Gov, laws.e-gov.go.jp (Japanese)

12. Related JPRO Pages

  • DMAH: Designated Marketing Authorization Holder – Summary Ver.
  • How to confirm the JMDN of a medical device
  • Classification of Medical Devices
  • Medical device classification for combined products
  • Combination Products, Combination Medical Devices, Kit Products, Kit Components, Assortment Products
  • Cosmetics and Quasi-Drugs
  • Medical Device vs Non-Medical Device (positioning)
  • Guidance for non-medical services
  • Therapeutic Orthoses and Assistive Devices
  • Overseas Expansion of Non-Medical Device Products as Medical Devices: the Case of PARO
  • Comparison of Medical Device Definitions: Japan, US, & EU
  • IVD, LDT, RUO
  • PMDA consultation
  • MEDISO free consultation service
Table of Contents 
About ​JPRO

​
Services
Contact Us
​​コンテンツ一覧
​
オフィス概要

【免責事項】
本サイトに掲載する情報は、厚生労働省、経済産業省、PMDA等の公的機関が発行する一次資料に基づき、正確性を期して作成していますが、その完全性、正確性、最新性を保証するものではありません。法規制は改正されることがあり、掲載情報が最新でない場合があります。本サイトの情報は一般的な情報提供を目的としたものであり、個別の薬事・法務・知財・税務等に関する専門的助言に代わるものではありません。具体的な判断や手続きにあたっては、必ず所管の規制当局または専門家にご確認ください。本サイトの情報に基づいて行われたいかなる行為についても、JPROは一切の責任を負いません。

【Disclaimer】
The information on this site is based on primary sources issued by Japanese government agencies (MHLW, METI, PMDA, etc.) and is prepared with the aim of accuracy. However, JPRO does not guarantee its completeness, accuracy, or currency. Regulations are subject to change, and the information may not reflect the latest amendments. The content is provided for general informational purposes only and does not constitute professional advice on regulatory, legal, intellectual property, or tax matters. For specific decisions or procedures, always consult the relevant regulatory authorities or qualified professionals. JPRO assumes no liability for any actions taken based on the information provided on this site.

本サイトは、ヘルスケア領域での起業・社会実装を目指す方のための情報サイトです。公的機関でアドバイザーを務める著者が、起業家が十分な知識を持ち、外部に過度に依存せず主体的に事業化を進められるよう、プロボノ活動の一環として運営しています。薬事等の法規制から資金調達、事業開発、知財など必要な情報をワンストップで収集できます。掲載情報は信頼性の高い公的機関の一次資料に基づいています。
This portal supports international healthcare enterprises and innovators expanding into the Japanese market. Operated as a pro bono initiative by an advisor to Japanese public institutions, the site is designed to equip you with the knowledge needed to advance your business proactively, without over-reliance on external consultants. From regulatory affairs to business setups, all content is sourced only from highly reliable public institutions. ©2026 JPRO
  • Home
    • English Top
    • 日本語トップ
  • Table of Contents (English)
    • Business Setup & Operations >
      • Startup Visa
      • Setting up a Business in Japan
      • ​How Foreign Startups Can Raise Funds in Japan
      • Company establishment
      • Life Science Hub, Startup Hub
    • Public Support >
      • Home-Country Public Support for Entering the Japanese Market
      • Using JETRO for Japan Market Entry|JPRO
      • Public Support in Yokohama city
    • Regulatory & Compliance >
      • PMDA Consultation Guide for Foreign Companies | RS Consultation | JPRO
      • Guide to Selecting Regulatory Affairs Staff and Consultants
      • Expedited Review Systems for Pharmaceuticals
      • Guidelines for Establishing Generic Drug Names
      • Combination Products, Combination Medical Devices, Kit Products, Combination Drugs
    • Medical Device, IVD >
      • IVD, LDT, RUO
      • DMAH: Designated Marketing Authorization Holder-Summary Ver.
      • Combination Products, Combination Medical Devices, Kit Products, Kit Components, Assortment Products
      • How to determine if a product is a medical device
      • Japan Medical Device Class I–IV|JPRO
      • Classification of Medical Devices
      • how to confirm JMDN of medical device
      • medical device & IVD reimbursement-Summary Ver.
      • medical device & IVD reimbursemenet
      • Comparison of Medical Device Definitions: Japan, US, & EU
      • Companion Diagnostics and Gene Panel Testing
    • Pharmaceutical, regenerative medicine >
      • How to determine if a product is a Pharmaceutical Drug
      • Advanced Medical Care System
      • Over-The-Counter (OTC) Drug
      • References on Reimbursement (Cost Calculation) for Regenerative Medical Products
    • Healthcare & Caretech Products >
      • guidance for non medical services
      • Therapeutic Orthoses and Assistive Devices
      • Cosmetics and Quasi-Drugs
      • Overseas Expansion of Non-Medical Device Products as Medical Devices: Learning from the Case of PARO
      • Medical Device vs Non-Medical Device
    • Funding, Partnering & Networking >
      • Utilization of Public Grants and Subsidies
      • J-Ships
    • Intellectual Property >
      • patent or trade secret?
      • employee invention
      • Matching of Patents Held by Startups and Individuals
    • Legal & Contracts >
      • References for Contracts
      • Guide to Industry-Academia Collaboration Agreements for Academic Researchers
    • Licensing, partnering >
      • Networking & Partnering in Japan for Life Science | JPRO
      • Introducing Seeds to Pharmaceutical Companies
      • Incentives (Returns) to Licensor Universities
    • References in English
  • コンテンツ一覧
    • 起業、法人設立・運営 >
      • 事業計画の策定
      • 法人設立
      • ライフサイエンスハブ、スタートアップハブ
    • 公的支援 >
      • 公的支援機関リスト|目的別で探す|JPRO
      • AMED 支援リスト
      • NEDOスタートアップ支援リスト
      • 実証実験支援プログラム一覧
      • 橋渡し研究・公的アクセラレーション・伴走支援一覧|JPRO
      • アカデミア発スタートアップ支援機関・プログラムガイド
    • 薬事・規制関連 >
      • PMDA RS相談活用のススメ
      • 薬事スタッフ・コンサル選定ガイド
      • 都道府県薬務課一覧
      • コンビネーション製品、組合せ医療機器、キット製品、組合せ医薬品
      • グレーゾーン解消制度、新事業特例制度、規制のサンドボックス
    • 医薬品、再生医療等製品 >
      • 医薬品の該当性確認方法
      • 医薬品一般的名称設定のガイドライン
      • 医薬品、医療機器等の開発に当たって参照したい資料
      • 先進医療制度
      • 一般用医薬品(OTC)
      • コンパニオン診断薬と遺伝子パネル検査
      • 再生医療等製品の保険償還(原価計算)に関する参考情報
    • 医療機器、体外診断用医薬品 >
      • 体外診、ラボ開発検査、研究用試薬
      • 医療機器該当性確認ガイド
      • 医療機器と非医療機器の機能が複合した製品は?
      • 医療機器の一般的名称と確認方法
      • 医療機器クラス分類(I〜IV)一覧と調べ方|JPRO
      • 医療機器・体外診の保険収載概要
      • 医療機器・体外診の保険収載実務
      • SaMDの保険収載
      • 医療機器・体外診の保険収載ガイド
    • ヘルスケア・ケアテック >
      • 非医療分野の検査サービスを展開する際に注意すべきポイント
      • 治療用装具と補装具
      • 化粧品及び医薬部外品
      • 医療機器 vs 非医療機器|ポジショニング戦略の検討ポイント|JPRO
    • 資金調達 >
      • 資金調達方法を知る
      • 公的な助成金、補助金の活用
      • 特定投資家向け銘柄制度(J-Ships)
      • アカデミア研究者がPIとして応募可能なグラントリスト
      • 海外在住の日本人研究者が日本の助成金を獲得する方法
      • 日本企業が現地法人設立せずに応募可能な助成金等リスト
    • 知的財産 >
      • アカデミア研究者・産学連携部門のための 知財に関する公的支援プロӞ
      • 特許か?営業秘密か?
      • 職務発明:アカデミア・公的研究機関に所属する研究者が注意すべきポ
      • スタートアップや個人が保有する特許のマッチング
      • ライセンスを受けた大学へのインセンティブ(還元)について
    • 法務・契約 >
      • 契約関連で参考になる公的機関の資料
      • 個人情報を利用する製品開発時に留意すべき法規制
    • アカデミア、技術移転 >
      • アカデミア研究者のための産学連携契約ガイド
    • ライセンシング、パートナリング >
      • 製薬企業等へのシーズ紹介
      • ネットワーキング、パートナリング
    • 海外展開 >
      • 米国展開(主に医療機器)に、読むと役立つ情報リスト
      • 米国FDAにおける、医療機器該当性の確認ステップ
      • 米国における、医療機器の申請データ・試験計画の相談方法((Pre-Submission/Q-Submission
      • 公的機関の海外展開支援
      • 横浜市の公的支援サービス
      • JETROを徹底活用しよう
      • 日米欧での医療機器定義の比較
      • 簡略審査(審査の迅速化)
      • 海外規制等の情報収集
      • 非医療機器製品の海外での医療機器展開
      • 欧州医療機器規則MDRに関する資料
      • 欧州MDRにおける、医療機器該当性の確認方法
    • オーストラリア >
      • オーストラリア研究開発優遇税制の概要
      • オーストラリア研究開発優遇税制の適用を受けるには
      • オーストラリアでの主要イベント
      • R&D関連の公的機関
      • オーストラリア助成金情報